- 英文名称
- Norgestimate
- 分子式
- C23H31NO3
- 分子量
- 369.5
- 中文别名
- 诺孕酪; 炔诺肟酯; 诺孕脂; 诺孕酮杂质; 诺孕酯NORGESTIMATE; 炔诺圬酯; (8R,9S,10R,13S,14S,17R)-13-乙基-17-乙炔基-3-(肟基)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊并[a]菲-17-基 乙酸酯; (8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-3-(hydroxyimino)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate; (3E,8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-3-(hydroxyimino)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate; (+)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one Oxime Acetate (Ester); d-17beta-acetoxy-13beta-ethyl-17alpha-ethinyl-gon-4en-3-one oxime; dexnorgestrelacetime; Norgestimat; levonorgestrel acetate 3-oxime; (3E,8R,9S,10R,13S,14S,17R)-17-Ethinyl-13-ethyl-3-(hydroxyimino)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ylacetat; 13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl acetate; (17R)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one oxime; (17α)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-Oxime; (17a)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-Oxime; D-138; (17-alpha)-17-(acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one3-oxime
- 用途
- 作为合成的孕激素类似物,是一种具有口服活性、高度选择性孕激素活性且雄激素作用小的孕激素,可用于口服避孕药;在体外研究中可转化为至少两种活性代谢物:左炔诺孕酮3-肟(去乙酰诺孕酯;诺孕曲明)和左炔诺孕酮